2002
DOI: 10.1006/exnr.2002.7998
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Strategies Targeting Caspase Inhibition Following Spinal Cord Injury in Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0
4

Year Published

2004
2004
2013
2013

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(27 citation statements)
references
References 27 publications
2
21
0
4
Order By: Relevance
“…The anti-caspase-3 activity of rMSC is attributable to downregulation of apoptotic proteins of the extrinsic pathway, which altered the number of caspase-3-positive cells. Similar to our studies, reduction of caspase activity by synthetic peptide-based inhibitors has been demonstrated to attenuate neuronal apoptosis and the spread of secondary damage in animal models of CNS trauma (39,40).…”
Section: Discussionsupporting
confidence: 88%
“…The anti-caspase-3 activity of rMSC is attributable to downregulation of apoptotic proteins of the extrinsic pathway, which altered the number of caspase-3-positive cells. Similar to our studies, reduction of caspase activity by synthetic peptide-based inhibitors has been demonstrated to attenuate neuronal apoptosis and the spread of secondary damage in animal models of CNS trauma (39,40).…”
Section: Discussionsupporting
confidence: 88%
“…This genetic rationale, however, fails to explain rat substrain differences observed in the literature. [7][8][9] Substrain differences in experimental nervous system models in rats have been reported for neuropathic pain behavior, startle reflex, and spinal noradrenergic neuron projections. [10][11][12] Nothing, however, has been reported on rat substrain differences in outcome after experimental spinal cord injury.…”
Section: Introductionmentioning
confidence: 99%
“…This includes the early infiltration of the injured spinal cord with neutrophils followed by microglial activation and persistent lymphocytic involvement chronically (67). Proand anti-apoptotic mechanisms are in play after SCI, and therapeutic strategies to regulate or inhibit apoptosis have been shown to improve outcome after experimental SCI (70,71). Inhibition of apoptosis by estrogen was shown to improve functional recovery after SCI in adult male rats through calpain inhibition (72).…”
Section: Review Of Animal Modelsmentioning
confidence: 99%